
| Dosaggio del prodotto: 200 mg | |||
|---|---|---|---|
| Confezione (n.) | Per compresse | Prezzo | Acquista |
| 90 | €0.43
Migliore per compresse | €38.46 (0%) | 🛒 Aggiungi al carrello |
| Dosaggio del prodotto: 300 mg | |||
|---|---|---|---|
| Confezione (n.) | Per compresse | Prezzo | Acquista |
| 60 | €0.61 | €36.76 (0%) | 🛒 Aggiungi al carrello |
| 90 | €0.57
Migliore per compresse | €55.13 €51.29 (7%) | 🛒 Aggiungi al carrello |
| Dosaggio del prodotto: 400 mg | |||
|---|---|---|---|
| Confezione (n.) | Per compresse | Prezzo | Acquista |
| 60 | €0.77 | €46.16 (0%) | 🛒 Aggiungi al carrello |
| 90 | €0.71
Migliore per compresse | €69.24 €64.11 (7%) | 🛒 Aggiungi al carrello |
Sinonimi | |||
More info:
Popular Products
Vibramycin
Vibramycin is a branded formulation of doxycycline, a broad-spectrum tetracycline antibiotic. This monograph details its clinical uses beyond infection, including for rosacea and periodontal disease, with a focus on its anti-inflammatory properties. Learn about the evidence-based dosage, key contraindications, and how its unique pharmacokinetic profile informs its therapeutic application in modern practice. Let’s talk about Vibramycin. In the clinic, it’s one of those agents that sits in a unique category—not just an antibiotic anymore, really.
Diclofenac SR
Diclofenac SR, or diclofenac sodium in a sustained-release formulation, is a cornerstone non-steroidal anti-inflammatory drug (NSAID) used globally. It belongs to the phenylacetic acid derivative class and is a potent inhibitor of cyclooxygenase (COX) enzymes, which are central to the inflammatory process. The “SR” designation—Sustained Release—is the critical differentiator from its immediate-release counterparts. This monograph provides a comprehensive, evidence-based review of Diclofenac SR, detailing its pharmacokinetics, therapeutic applications, safety profile, and clinical nuances essential for both prescribing healthcare professionals and informed patients.
Hypernil
Hypernil: A comprehensive, evidence-based review of this nitric oxide support formula for cardiovascular and endothelial health. Learn about the unique mechanism of action, key clinical studies on blood flow and blood pressure, and practical guidance for use. Understand the science behind Hypernil’s targeted ingredients and how it compares to other vasodilatory supplements. Let’s talk about Hypernil. In my practice, we see a constant stream of patients—mostly middle-aged and beyond—who are on the standard cardiometabolic conveyor belt.
Augmentin: Potent Antibacterial Therapy for Bacterial Infections - Evidence-Based Review
Augmentin isn’t your typical antibiotic. It’s a workhorse, a combination therapy that’s been on the front lines of bacterial infections for decades. When I think about it, I don’t just see a pill; I see a strategic response to one of bacteria’s oldest tricks: the production of beta-lactamase enzymes. These enzymes are like molecular scissors that many bacteria use to snip apart and deactivate penicillins. Amoxicillin alone is excellent, broad-spectrum, and well-tolerated.
Flexeril
Let’s talk about Flexeril. It’s one of those drugs that’s been in the toolkit for decades—since the 70s, actually—and you either have a comfort zone with it or you’ve seen enough side effects to be wary. Officially, it’s cyclobenzaprine hydrochloride, a centrally-acting skeletal muscle relaxant. But in the trenches of primary care and ortho clinics, it’s that script we reach for when a patient hobbles in with an acute back spasm, often after a weekend of overdoing it.
Silagra: Effective Erectile Dysfunction Treatment - Evidence-Based Review
Product Description Silagra is an oral pharmaceutical tablet containing sildenafil citrate, a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). It is indicated for the treatment of erectile dysfunction (ED) in adult men. By enhancing the natural nitric oxide (NO)-mediated relaxation of cavernosal smooth muscle, Silagra facilitates the inflow of blood necessary for an erection following sexual stimulation. It is not an aphrodisiac and requires psychosexual stimulation for efficacy.
Rizact: Targeted Neuropathic Pain Relief Through Modulated Neuromodulation - Evidence-Based Review
Product Description: Rizact is a Class IIa medical device, specifically a non-invasive, transcutaneous electrical nerve stimulation (TENS) unit with integrated microcurrent and modulated frequency technology. It is indicated for the symptomatic relief of chronic, neuropathic pain, particularly in conditions like diabetic peripheral neuropathy and post-herpetic neuralgia. Unlike standard TENS, Rizact employs a proprietary waveform algorithm designed to not just mask pain signals but to potentially modulate the underlying neuropathic dysfunction.
Clozaril (Clozapine): A Critical Tool in Treatment-Resistant Schizophrenia - Evidence-Based Review
Product Description: Clozaril, known generically as clozapine, is not a dietary supplement or a medical device. It is a second-generation (atypical) antipsychotic medication, classified as a prescription pharmaceutical. It is primarily indicated for the treatment of severe schizophrenia in patients who have not responded adequately to standard antipsychotic therapies, and for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. Its unique efficacy profile is counterbalanced by a significant risk of serious adverse effects, most notably agranulocytosis, necessitating a strict, federally mandated risk evaluation and mitigation strategy (REMS) program involving continuous blood monitoring.
Renagel
Renagel (sevelamer hydrochloride) is a phosphate binder used to manage hyperphosphatemia in chronic kidney disease patients on dialysis. This comprehensive monograph details its mechanism of action, clinical evidence, and practical use guidelines. Learn about its role in reducing cardiovascular risk and how it compares to other binders in modern nephrology practice. Let’s talk about Renagel. If you’re in nephrology, you know the name. It’s not a new drug, but its story and its place in our toolkit for managing dialysis patients is more nuanced than the monograph leaflet suggests.














